We are live on ! Find out more
TRIB

Trinity Biotech
TRIB

52 hedge funds and large institutions have $81.5M invested in Trinity Biotech in 2017 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 15 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0.09% less ownership

Funds ownership: 3.15% → 3.06% (-0.09%)

7% less funds holding

Funds holding: 56 → 52 (-4)

9% less capital invested

Capital invested by funds: $89.6M → $81.5M (-$8.1M)

20% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 15

43% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 7

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $73K

Holders
52
Holders Change
-4
Holders Change %
-7.14%
% of All Funds
1.3%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
4
Increased
12
Reduced
15
Closed
7
Calls
–
Puts
$73K
Net Calls
-$73K
Net Calls Change
+$28K

Top Buyers

Rank Fund Capital Flow
1
SM
Senvest Management
New York
+$997K
2
Morgan Stanley
Morgan Stanley
New York
+$855K
3
KCM
Kennedy Capital Management
Missouri
+$547K
4
Russell Investments Group
Russell Investments Group
United Kingdom
+$453K
5
Boston Partners
Boston Partners
Massachusetts
+$452K

Top Sellers

Rank Fund Capital Flow
1
RA
Royce & Associates
New York
-$1.09M
2
SCM
Stonepine Capital Management
Oregon
-$1.06M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$967K
4
HA
Heartland Advisors
Wisconsin
-$879K
5
CSC
Cove Street Capital
California
-$603K
Name Holding Trade Value Shares
Change 		Change in
Stake
SKK
26
Shepherd Kaplan Krochuk
Massachusetts
$361K -$16.7K -600 -4%
Two Sigma Advisers
27
Two Sigma Advisers
New York
$283K -$27K -968 -9%
BCA
28
Benchmark Capital Advisors
New York
$213K -$12.8K -458 -6%
State Street
29
State Street
Massachusetts
$213K +$2.18K +78 +1%
RJA
30
Raymond James & Associates
Florida
$183K +$41.9K +1,501 +30%
PCM
31
Proxima Capital Management
New York
$165K – – –
California Public Employees Retirement System
32
California Public Employees Retirement System
California
$158K – – –
WS
33
Wedbush Securities
California
$156K -$2.51K -90 -2%
OAM
34
Oxford Asset Management
United Kingdom
$105K +$31.9K +1,145 +44%
RC
35
RBF Capital
California
$84K – – –
BO
36
BRR OpCo
Ohio
$79K +$78.8K +2,827 New
TRCT
37
Tower Research Capital (TRC)
New York
$69K +$56.7K +2,034 +475%
MCC
38
Malaga Cove Capital
California
$31K +$31.8K +1,140 New
WAS
39
WESPAC Advisors SoCal
California
$29K – – –
Bank of Montreal
40
Bank of Montreal
Ontario, Canada
$18K – – –
JCM
41
Jacobi Capital Management
Pennsylvania
$10K – – –
Bank of America
42
Bank of America
North Carolina
$6K -$34.2K -1,227 -84%
WT
43
Whittier Trust
California
$6K – – –
AG
44
Advisor Group
Arizona
$5K – – –
RE
45
RBC Europe
United Kingdom
$4.44K +$4.41K +158 New
Citigroup
46
Citigroup
New York
$3K – – –
Royal Bank of Canada
47
Royal Bank of Canada
Ontario, Canada
$3K – – –
AIM
48
Advantage Investment Management
Iowa
$2K – – –
IA
49
IFP Advisors
Florida
$2K – – –
FDCDDQ
50
Federation des caisses Desjardins du Quebec
Quebec, Canada
$1.4K – – –
1
2
3

TRIB Hedge Fund Activity: Q3 2017 in Review

52 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Trinity Biotech (TRIB) for Q3 2017, worth a combined $81.5M — down 9% from $89.6M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of TRIB and 4 opened new positions — a net loss of 3 holders — while 15 trimmed existing stakes and 12 added.

The largest buyer was Senvest Management, adding an estimated $997K. The largest seller was Royce & Associates, exiting entirely with an estimated $1.09M sold.

  • 52 institutional investors held Trinity Biotech (TRIB) as of Q3 2017, down from 56 in Q2 2017.
  • Funds reported $81.5M of Trinity Biotech stock for Q3 2017, down 9% quarter-over-quarter.
  • 4 funds opened new Trinity Biotech positions in Q3 2017 and 7 closed out, a net change of -3 holders.
  • The largest Trinity Biotech buyer in Q3 2017 was Senvest Management, an estimated $997K added.
  • The largest Trinity Biotech seller in Q3 2017 was Royce & Associates, an estimated $1.09M sold.

Based on aggregated 13F filings for Q3 2017.